Suchergebnisse - "Wittayer, Matthias Sebastian"

PubPharm (9)

1

Cerebrospinal fluid-related tissue damage in multiple sclerosis patients with iron rim lesions

enthalten in: Multiple sclerosis journal | Apr 2023

von Wittayer, M. | Weber, C. | Kittel, M. | +5

2

Epidemiologische Untersuchung zu möglichen Auswirkungen öffentlicher Kommunikation im Rahmen der COVID-19-Pandemie auf Notfallvorstellungen von Kopfschmerzpatient*innen

enthalten in: Das Gesundheitswesen | 08. Dezember 2023

von Wittayer, M. | Sandikci, V. | Ebert, A. | +3

3

Impact of disease-modifying therapies on evolving tissue damage in iron rim multiple sclerosis lesions : short report

enthalten in: Multiple sclerosis journal | December 2022

von Eisele, P. | Wittayer, M. | Weber, C. | +3

4

IMI2-PainCare-BioPain-RCT2 protocol : a randomized, double-blind, placebo-controlled, crossover, multicenter trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by non-invasive neurophysiological measurements of human spinal cord and brainstem activity

enthalten in: Trials | 05 September 2022

von Leone, C. | Di Stefano, G. | Di Pietro, G. | +25

5

Spatial distribution of multiple sclerosis iron rim lesions and their impact on disability

enthalten in: Multiple Sclerosis and Related Disorders | August 2022

von Wittayer, M. | Weber, C. | Platten, M. | +3

6

Long-term dynamics of multiple sclerosis iron rim lesions

enthalten in: Multiple Sclerosis and Related Disorders | 2022

von Weber, C. | Wittayer, M. | Kraemer, M. | +6

7

Impact of disease-modifying therapies on evolving tissue damage in iron rim multiple sclerosis lesions

Erschienen: London, Sage, 22 Feb. 2023

von Eisele, P. | Wittayer, M. | Weber, C. | +3

8

Sex-specific differences in pre-stroke characteristics reveal vulnerability of elderly women

enthalten in: Journal of Personalized Medicine | 24 February 2022

von Hoyer, C. | Schlenker, J. | Sandikci, V. | +4

9

IMI2-PainCare-BioPain-RCT3 : a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by electroencephalography (EEG)

enthalten in: Trials | 17 June 2021

von Mouraux, A. | Bloms-Funke, P. | Boesl, I. | +22

1
[1]